Cassava Historical Financial Ratios
| SAVA Stock | USD 1.75 0.15 7.89% |
Cassava Sciences is presently reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0, Average Payables of 1.8 M, Capex To Depreciation of 0.0864 or Pb Ratio of 0.46 will help investors to properly organize and evaluate Cassava Sciences financial condition quickly.
Cassava |
About Cassava Financial Ratios Analysis
Cassava SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cassava Sciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cassava financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cassava Sciences history.
Cassava Sciences Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Cassava Sciences dividend as a percentage of Cassava Sciences stock price. Cassava Sciences dividend yield is a measure of Cassava Sciences stock productivity, which can be interpreted as interest rate earned on an Cassava Sciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from Cassava Sciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cassava Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.At present, Cassava Sciences' EV To Sales is projected to decrease significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 0.14, whereas Price To Sales Ratio is projected to grow to (103 K).
| 2022 | 2023 | 2025 (projected) | PB Ratio | 0.75 | 0.98 | 0.46 | Capex To Depreciation | 2.08 | 0.27 | 0.0864 |
Cassava Sciences fundamentals Correlations
Click cells to compare fundamentals
Cassava Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cassava Sciences fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 0.59 | 0.28 | 0.97 | 0.75 | 0.98 | 0.46 | |
| Book Value Per Share | 3.53 | 6.44 | 5.66 | 3.28 | 3.14 | 2.99 | |
| Operating Cash Flow Per Share | (0.21) | (0.77) | (1.93) | (1.96) | (2.52) | (2.4) | |
| Pb Ratio | 0.59 | 0.28 | 0.97 | 0.75 | 0.98 | 0.46 | |
| Free Cash Flow Per Share | (0.21) | (1.33) | (2.0) | (1.97) | (2.53) | (2.4) | |
| Roic | (0.2) | (0.0644) | (0.13) | (0.77) | (0.89) | (0.84) | |
| Net Income Per Share | (0.22) | (0.81) | (1.8) | (2.32) | (0.53) | (0.55) | |
| Payables Turnover | 0.23 | 0.13 | 0.38 | 0.0749 | 0.32 | 0.14 | |
| Cash Per Share | 3.58 | 5.92 | 5.0 | 2.89 | 2.78 | 2.64 | |
| Pocfratio | (4.73) | (8.14) | (2.19) | (1.65) | (0.94) | (0.98) | |
| Pfcf Ratio | (4.73) | (4.69) | (2.11) | (1.64) | (0.93) | (0.98) | |
| Days Payables Outstanding | 961.03 | 4.9K | 1.1K | 2.5K | 2.9K | 2.8K | |
| Income Quality | 0.85 | 0.93 | 1.02 | 0.84 | 4.8 | 5.04 | |
| Roe | (0.0635) | (0.13) | (0.32) | (0.71) | (0.17) | (0.18) | |
| Ev To Operating Cash Flow | 12.59 | (0.42) | 0.4 | (0.17) | 0.16 | 0.17 | |
| Pe Ratio | (4.34) | (7.73) | (2.34) | (1.39) | (4.49) | (4.27) | |
| Return On Tangible Assets | (0.0621) | (0.12) | (0.31) | (0.64) | (0.15) | (0.16) | |
| Ev To Free Cash Flow | 12.59 | (0.24) | 0.39 | (0.17) | 0.16 | 0.17 | |
| Earnings Yield | (5.06) | (0.33) | (0.23) | (0.13) | (0.72) | (0.22) | |
| Net Debt To E B I T D A | 5.03 | 14.77 | 7.32 | 2.68 | 1.14 | 1.08 | |
| Current Ratio | 50.4 | 19.51 | 29.91 | 9.13 | 11.62 | 15.5 | |
| Tangible Book Value Per Share | 3.53 | 6.42 | 5.64 | 3.27 | 3.14 | 2.99 | |
| Shareholders Equity Per Share | 3.53 | 6.44 | 5.66 | 3.28 | 3.14 | 2.99 | |
| Graham Net Net | 3.5 | 5.6 | 4.82 | 2.57 | 2.52 | 2.39 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.